The transcriptional landscape of atrial fibrillation: A systematic review and meta-analysis

S Sergio Alejandro Gómez-Ochoa M Malte Möhn M Michelle Victoria Malz R Roger Ottenheijm J Jan D. Lanzer F Felix Wiedmann M Manuel Kraft T Taulant Muka C Constanze Schmidt M Marc Freichel (Department of General Pharmacology, Pharmakologisches Institut, Universität Heidelberg) R Rebecca T. Levinson

Abstract

Background Despite advances in understanding atrial fibrillation (AF) pathophysiology, there is limited agreement on the key genes driving its pathophysiology. To understand the genome-wide transcriptomic landscape, we performed a meta-analysis from studies reporting gene expression patterns in atrial heart tissue from patients with AF and controls in sinus rhythm (SR). Methods Bibliographic databases and data repositories were systematically searched for studies reporting gene expression patterns in atrial heart auricle tissue from patients with AF and controls in sinus rhythm. We calculated the pooled differences in individual gene expression from fourteen studies comprising 534 samples (353 AF and 181 SR) to create a consensus signature (CS), from which we identified differentially regulated pathways, estimated transcription factor activity, and evaluated its performance in classifying validation samples as AF or SR. Results Despite heterogeneity in the top differentially expressed genes across studies, the AF-CS in both chambers were robust, showing a better performance in classifying AF status than individual study signatures. Functional analysis revealed commonality in the dysregulated cellular processes between chambers, including extracellular matrix remodeling (highlighting epithelial mesenchymal transition, actin filament organization, and actin binding hallmark pathways), cardiac conduction (including cardiac muscle cell action potential, gated channel activity, and cation channel activity pathways), metabolic derangements (highlighting oxidative phosphorylation and asparagine n linked glycosylation), and innate immune system activity (mainly neutrophil degranulation, and TNFα signaling pathways). Finally, the AF-CS showed a good performance differentiating AF from controls in three validation datasets (two from peripheral blood and one from left ventricle samples). Conclusions Despite variability in individual studies, this meta-analysis elucidated conserved molecular pathways involved in AF pathophysiology across its phenotypes and the potential of a transcriptomic signature in identifying AF from peripheral blood samples. Our work highlights the value of integrating published transcriptomics data in AF and the need for better data deposition practices.

Article Details

Journal PLoS ONE
Volume / Issue Vol. 20, Issue 5
Published May 30, 2025
Pages e0323534
ISSN 1932-6203
Publisher Public Library of Science

Journal Info

PLoS ONE

Public Library of Science

ISSN: 1932-6203 Open Access Health Sciences

Authors (11)

S

Sergio Alejandro Gómez-Ochoa

M

Malte Möhn

M

Michelle Victoria Malz

R

Roger Ottenheijm

J

Jan D. Lanzer

F

Felix Wiedmann

M

Manuel Kraft

T

Taulant Muka

C

Constanze Schmidt

M

Marc Freichel

Department of General Pharmacology, Pharmakologisches Institut, Universität Heidelberg

R

Rebecca T. Levinson